Sana Biotechnology Inc. (NASDAQ:SANA) is one of the most promising penny stocks under $5 to buy. On February 17, Sana ...

Life Sciences Investors delivered a 40.59% NAV return in 2025, supported by innovation-focused biotechnology. Read the full ...

Guidance language shifted to a more specific projection of 15%-20% operating expense growth for 2026, compared to less specific spending outlook in Q3. Management's confidence increased, underpinned ...

(PBYI) on Thursday reported earnings of $13.4 million in its fourth quarter. The Los Angeles-based company said it had net income of ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the fourth ...

Vir Biotechnology Inc. (NASDAQ:VIR) shares fell 16% Thursday after the company announced the pricing of an underwritten public offering at $8.50 per share, a 15% ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the fourth quarter and fiscal year ended December ...

Kerry Group outlines its post‑divestment strategy, focusing on innovation, reformulation, global channel growth and digital ...

Woodward, Inc.: a significant win for the county’s aerospace sector, Woodward announced it would invest nearly $200 million to establish operations in Spartanburg County, creating 275 new jobs. The ...

Akston, a biotechnology company focused on animal health, has opened a new manufacturing facility as part of a $7 million investment in Caddo Parish.

Longstanding Republican orthodoxy on free markets and scant details are making Trump’s drug pricing law push difficult.

At first glance, the European Commission’s Biotech Act proposal may appear as another sectoral initiative aimed at boosting innovation. On closer reading, however, it signals something far more ...